Stock Events

Stock Events

Edwards Lifesciences 

R$105.71
295
-R$0.22-0.21% Monday 19:47

Statistics

Day High
105.71
Day Low
105.71
52W High
122.51
52W Low
94.3
Volume
0
Avg. Volume
49
Mkt Cap
60.93B
P/E Ratio
48.71
Dividend Yield
-
Dividend
-

Upcoming

Earnings

28OctExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.55
0.63
0.7
0.78
Expected EPS
0.738267
Actual EPS
N/A

Financials

17.54%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
33.65BRevenue
5.9BNet Income

Analyst Ratings

184.10Average Price Target
The highest estimate is 197.65.
From 13 ratings within the last 6 months. This is not an investment recommendation.
Buy
77%
Hold
23%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow E1WL34.SA. It's not an investment recommendation.
Apple
79
AAPL
Microsoft
74
MSFT
Alphabet
74
GOOGL
NVIDIA
71
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.77B
Medtronic competes directly with Edwards Lifesciences in the heart valve market, including transcatheter aortic valve replacement (TAVR) technologies.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific competes in the interventional cardiology space, offering products that rival Edwards Lifesciences' heart valve solutions.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories offers a range of cardiovascular devices, including mitral and tricuspid valve repair and replacement technologies that compete with Edwards' offerings.
Stryker
SYK
Mkt Cap126.84B
Stryker competes in the medical devices sector, including neurotechnology and spine products, which can be seen as indirect competition to Edwards Lifesciences' cardiovascular focus.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its medical devices segment, competes across various healthcare sectors, including cardiovascular, which puts it in competition with Edwards Lifesciences.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet, primarily known for orthopedics, has ventured into the cardiovascular space, positioning it as a competitor to Edwards Lifesciences.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical's robotic-assisted surgical systems can be used in cardiovascular surgeries, indirectly competing with Edwards Lifesciences' surgical heart valve solutions.
Edwards Lifesciences
EW
Mkt Cap52B
Edwards Lifesciences competes with itself through its diverse range of heart valve products, constantly innovating to replace its older technologies.
Baxter International
BAX
Mkt Cap13.51B
Baxter International competes in the broader medical devices market, including products for critical care, which can overlap with Edwards Lifesciences' cardiovascular focus.
Integra Lifesciences
IART
Mkt Cap1.31B
Integra LifeSciences, while more focused on neurosurgery and regenerative technologies, competes in the medical devices market, offering some products that can be used in cardiovascular procedures.

About

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Show more...
CEO
Bernard J. Zovighian
Employees
16000
Country
United States
ISIN
BRE1WLBDR000

Listings

STU
DE
EWL.STU
MU
DE
EWL.MU
MX
MX
EW.MX
LSE
GB
0REN.LSE

0 Comments

Share your thoughts

FAQ

What is Edwards Lifesciences stock price today?▼
The current price of E1WL34.SA is R$105.71 BRL — it has decreased by -0.21% in the past 24 hours. Watch Edwards Lifesciences stock price performance more closely on the chart.
What is Edwards Lifesciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Sao Paolo Exchange exchange Edwards Lifesciences stocks are traded under the ticker E1WL34.SA.
Is Edwards Lifesciences stock price growing?▼
E1WL34.SA stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Edwards Lifesciences has showed a -3.8% decrease.
What is Edwards Lifesciences market cap?▼
Today Edwards Lifesciences has the market capitalization of 60.93B
When is the next Edwards Lifesciences earnings date?▼
Edwards Lifesciences is going to release the next earnings report on October 28, 2026.
What were Edwards Lifesciences earnings last quarter?▼
E1WL34.SA earnings for the last quarter are 3.98 BRL per share, whereas the estimation was 3.79 BRL resulting in a +4.97% surprise. The estimated earnings for the next quarter are N/A BRL per share.
What is Edwards Lifesciences revenue for the last year?▼
Edwards Lifesciences revenue for the last year amounts to 33.65B BRL.
What is Edwards Lifesciences net income for the last year?▼
E1WL34.SA net income for the last year is 5.9B BRL.
How many employees does Edwards Lifesciences have?▼
As of September 05, 2026, the company has 16,000 employees.
In which sector is Edwards Lifesciences located?▼
Edwards Lifesciences operates in the Health & Wellness sector.
When did Edwards Lifesciences complete a stock split?▼
The last stock split for Edwards Lifesciences was on June 01, 2020 with a ratio of 3:1.
Where is Edwards Lifesciences headquartered?▼
Edwards Lifesciences is headquartered in IRVINE, United States.